Kendle's experience developing, implementing, and managing pregnancy registries is unsurpassed. We currently manage more pregnancy registries than any other CRO.
Below are links to our active pregnancy registry web sites for use by both patients and physicians.
Amevive® Pregnancy Exposure Registry
Pregnant patients exposed to Amevive® within the 8 weeks prior to conception and during the pregnancy and who are still currently pregnant may contact the registry at:
Phone: 866-834-7223
Fax: 800-800-1052
Email: registries@kendle.com
Avonex® Pregnancy Exposure Registry
Pregnant patients exposed to Avonex® around the time of conception and during the first trimester of pregnancy and who are still currently pregnant may contact the registry at:
Phone: 800-811-0104
Fax: 800-800-1052
Email: registries@kendle.com
Pregnant patients or healthcare providers of pregnant patients exposed to Betaseron® at the time of conception (i.e., any time from the first day of the last menstrual period) and/or during pregnancy may contact the registry at:
Phone: 800-478-7049
Fax: 800-800-1052
Email: registries@kendle.com
http://www.cymbaltapregnancyregistry.com
Pregnant patients who have taken Cymbalta® at any time during pregnancy and their health care providers may contact The Cymbalta® Pregnancy Registry via:
Phone: 1-866-814-6975
Email: registries@kendle.com
http://www.exenatidepregnancyregistry.com
Pregnant patients or health care providers of pregnant patients exposed to exenatide (BYETTA® injection or other formulations of exenatide) and/or one or more other non-insulin antidiabetic medications at the time of conception (i.e., on or after the first day of the last menstrual period) may contact the registry at:
Phone: 800-633-9081
Email: registries@kendle.com
The Savella Pregnancy Registry
http://www.savellapregnancyregistry.com
Pregnant patients exposed to Savella during pregnancy
Phone: 1- 877.643.3010
Fax : 1.800.800.1052
Email: registries@kendle.com
Sumatriptan/Naratriptan/Treximet Pregnancy Registry
http://pregnancyregistry.gsk.com/sumatriptan.html
Phone: 800-336-2176
Additional forms are provided below:
pdf 22k |
|
pdf 9k |
|
pdf 27k |
Pregnant patients or health care providers of pregnant patients who have been exposed to Keppra® or other UCB antiepileptic drug (AED) prior to conception and during pregnancy may contact the UCB AED Pregnancy Registry (formerly, the Keppra Pregnancy Registry) via
Phone: 1-888-537-7734 (1-888-KEP-PREG)
Fax: 1-800-800-1052
Email: registries@kendle.com
Please reference www.keppra.com for prescribing information.